14,474 results found

In the April 8, 2015, Federal Register, FDA announced that, at the sponsor's request, it is withdrawing approval of a new animal drug application ("NADA") for a fomepizole injectable solution, which is used as an antidote for ethylene glycol poisoning in dogs.

In the October 13, 2015, Federal Register, FDA announced it is withdrawing approval of a NADA providing for the use of penicillin G procaine in medicated feed of poultry and swine.

Groups representing seed, grain, and packaged-food companies formed the Coalition for Safe Affordable Food in an attempt to prevent states from requiring labels on products containing GMOs

FDA's Center for Drug Evaluation and Research ("CDER") recently announced that Michael Kopcha will serve as permanent director of the Office of Pharmaceutical Quality ("OPQ").

In the February 22, 2017, Federal Register, USDA's Food Safety and Inspection Service ("FSIS") extended the comment period for a proposed rule to amend the nutrition labeling requirements...

These requirements also apply to raw beef products that are ground at an individual customer's request when new source materials are used.

In the November 16, 2015, Federal Register, USDA's FSIS issued an updated version of the Agency's compliance guidelines for controlling hazards posed by allergens and other ingredients of public health concern.

The U.S. Government Accountability Office (GAO) has conducted a study on how "use by" and "best by" dates on food products could be improved to reduce food waste.

The Natural Resources Defense Council filed a petition requesting en banc review of a three-judge panel ruling that FDA is not required to ban certain antibiotics in livestock feed.

Continuing an ongoing debate on the safety of cosmetic ingredients, Harvard School of Public Health hosted a talk on "Harmful and Untested Chemicals in Everyday Products."

The Department of Health and Human Services (HHS) has modified HIPAA retail pharmacy transaction requirements to differentiate between partial fill ...

The Administration has updated its regulatory agenda, which lists major pending or planned regulatory actions and the anticipated timing of rulemaking activity.

The Obama Administration has released its latest regulatory agenda, which lists major pending or planned regulatory actions and the anticipated timing of rulemaking activity.

HHS has proposed increasing from 100 to 200 the patient limit for qualified practitioners who prescribe buprenorphine-based medication-assisted treatment under the Controlled Substances Act to expand access to treatment for opioid use disorders.

The U.S. Department of Health and Human Services ("HHS") recently released its Agency Rule List—Spring 2015, which includes, among other things, expected timelines for rulemakings affecting the pharmaceutical industry.

On November 20, 2015, the Department of Health and Human Services (HHS) is hosting a public forum in Washington DC to explore pharmaceutical innovation, access, affordability and better health.

Joshua Horn authored the Cannabis Law Journal article, "High Times For Lawyers: Cannabis Law and the Rules of Professional Conduct."